Niels M. Graafland
YOU?
Author Swipe
View article: Evaluating follow‐up in patients with lymph node‐negative penile cancer at a high‐volume centre
Evaluating follow‐up in patients with lymph node‐negative penile cancer at a high‐volume centre Open
Objectives To evaluate the current European Association of Urology/American Society of Clinical Oncology follow‐up (FU) schedule with routine use of ultrasonography (US) ± US‐guided fine‐needle aspiration cytology (FNAC) in patients with l…
View article: Multicenter Evaluation of Morbidity and Predictors of Response to Imiquimod Treatment for Penile Intraepithelial Neoplasia
Multicenter Evaluation of Morbidity and Predictors of Response to Imiquimod Treatment for Penile Intraepithelial Neoplasia Open
View article: A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?
A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied? Open
Objectives: To determine the rate of benign pathology in cT1 tumors following partial nephrectomy in the Netherlands, thereby evaluating the rate of overtreatment. Methods: Data were collected from a nationwide database containing histopat…
View article: Comparison of Oncological and Functional Outcomes of Radical Versus Partial Nephrectomy for cT1b Renal Cell Carcinoma: A Two-Centre, Matched Analysis
Comparison of Oncological and Functional Outcomes of Radical Versus Partial Nephrectomy for cT1b Renal Cell Carcinoma: A Two-Centre, Matched Analysis Open
BACKGROUND: It remains unclear which patients with cT1b renal cell carcinoma (RCC) benefit most from partial nephrectomy (PN) versus radical nephrectomy (RN) considering oncological outcomes and renal function. OBJECTIVE: To compare oncolo…
View article: The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis
The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis Open
A network MTB creates opportunity to discuss multiple treatment options and clinical trials in SDM with patients at a high rate of adherence to MTB recommendation.
View article: Comparison of oncological and functional outcomes of radical versus partial nephrectomy for cT1b renal cell carcinoma: A two-center, matched analysis
Comparison of oncological and functional outcomes of radical versus partial nephrectomy for cT1b renal cell carcinoma: A two-center, matched analysis Open
View article: The impact of multi- and interdisciplinary tumour board (MTB) meetings on treatment decision making for patients with renal cell carcinoma (RCC): 5-year data analysis
The impact of multi- and interdisciplinary tumour board (MTB) meetings on treatment decision making for patients with renal cell carcinoma (RCC): 5-year data analysis Open
View article: EP13.09: Parental conditions, modifiable lifestyle factors and embryonic growth and development: a systematic review
EP13.09: Parental conditions, modifiable lifestyle factors and embryonic growth and development: a systematic review Open
Methods: We evaluated the three different trajectories against a referent, defined as no abrupt change in growth trajectory and EFW or AC between the 25th and 75th centile at the final scan.The three trajectories were categorised as Group …
View article: OP11.08: Discordant embryonic morphologic development in twin pregnancies: a case series
OP11.08: Discordant embryonic morphologic development in twin pregnancies: a case series Open
The prediction model provides useful information for counselling twin pregnancies regarding their risk for GDM that is above the general twin population.
View article: Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease? Open
View article: Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study
Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study Open
Objectives To analyse variation in clinical management of cT1 renal cell carcinoma (RCC) in the Netherlands related to surgical hospital volume (HV). Materials and methods Patients diagnosed with cT1 RCC during 2014–2020 were identified in…
View article: Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer
Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer Open
In this report, we looked at the outcomes of penile cancer patients in an expert centre undergoing various treatments on their pelvis. We found that survival is poor after recurrence despite locoregional treatment. Therefore, better system…
View article: Percutaneous cryoablation: a novel treatment option in non-visceral metastases of the abdominal cavity after prior surgery
Percutaneous cryoablation: a novel treatment option in non-visceral metastases of the abdominal cavity after prior surgery Open
View article: Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations
Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations Open
Patients experiencing recurrence of kidney cancer in an atypical site require a heavy treatment burden and have a guarded overall prognosis. Continued research is needed to determine the precise incidence of these recurrences and identify …
View article: Interactive virtual 3D image reconstruction to assist renal surgery in patients with fusion anomalies of the kidney
Interactive virtual 3D image reconstruction to assist renal surgery in patients with fusion anomalies of the kidney Open
Objective: Renal fusion anomalies are rare and usually present as horseshoe kidneys or crossed fusion ectopia. The complex renal anatomy seen in patients with these anomalies can present a challenge. Pre-operative planning is therefore par…
View article: Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment Open
View article: 737P Synchronous metastatic renal cell carcinoma (mRCC) treated with nivolumab and ipilimumab (N+I) and the primary tumour (PT) in place
737P Synchronous metastatic renal cell carcinoma (mRCC) treated with nivolumab and ipilimumab (N+I) and the primary tumour (PT) in place Open
View article: Shared decision making and study participation in renal cancer care; the value of centralized multidisciplinary team consultation of the Amsterdam Renal Cancer Network
Shared decision making and study participation in renal cancer care; the value of centralized multidisciplinary team consultation of the Amsterdam Renal Cancer Network Open
View article: Outcome after resection of isolated single- or oligometastatic lymph node metastases at the time of nephrectomy
Outcome after resection of isolated single- or oligometastatic lymph node metastases at the time of nephrectomy Open
View article: Ureterocolic fistula detected by mercaptoacetyltriglycine (MAG-3) diuretic renography including single photon emission CT and low-dose CT (SPECT–CT)
Ureterocolic fistula detected by mercaptoacetyltriglycine (MAG-3) diuretic renography including single photon emission CT and low-dose CT (SPECT–CT) Open
We describe the case of a 60‐year‐old man with a ureterocolic fistula following laparoscopic sigmoid resection. The fistulous tract between the left ureter and sigmoid colon was detected by mercaptoacetyltriglycine diuretic renography incl…
View article: MP14-01 USE OF FLUORODEOXYGLUCOSE (FDG) PET/CT FOR STAGING PELVIC LYMPH NODES IN 100 PATIENTS WITH PENILE CARCINOMA
MP14-01 USE OF FLUORODEOXYGLUCOSE (FDG) PET/CT FOR STAGING PELVIC LYMPH NODES IN 100 PATIENTS WITH PENILE CARCINOMA Open
You have accessJournal of UrologyImaging/Radiology: Uroradiology I1 Apr 2018MP14-01 USE OF FLUORODEOXYGLUCOSE (FDG) PET/CT FOR STAGING PELVIC LYMPH NODES IN 100 PATIENTS WITH PENILE CARCINOMA Sarah Ottenhof, Rosa Djajadiningrat, Niels Graa…